RogerAlanDonovickMD
Psychiatry • Los Angeles, CAAssistant Professor, Psychiatry, UCLA School of Medicine
Dr. Donovick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11301 Wilshire Blvd
691/129
Los Angeles, CA 90073Phone+1 310-478-3711
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1996 - 2000
New York Medical CollegeClass of 1996
Certifications & Licensure
OR State Medical License 2012 - Present
NE State Medical License 2014 - 2026
CA State Medical License 1998 - 2025
FL State Medical License 2021 - 2023- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 116 citationsAlvimopan: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction—A 21-day treatment-randomized clinical trialDaniel M. Paulson, Daniel T. Kennedy, Roger A. Donovick, Randall L. Carpenter, Maryann Cherubini
The Journal of Pain. 2005-03-01 - 33 citationsComparison of buprenorphine treatment for opioid dependence in 3 settings.Karen Miotto, Maureen Hillhouse, Roger Donovick, Jerry Cunningham-Rathner, Charlie Charuvastra
Journal of Addiction Medicine. 2012-03-01 - 10 citationsThe NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.Ahmed Elkashef, Richard A. Rawson, Edwina V. Smith, Valerie Pearce, Frank Flammino
Addiction. 2007-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
